NEAR-TERM MILESTONES from the Report:
Q1'11 Complete initial production of the Unifill Prefilled syringe in the qualified clean rooms of Unilife's facility in York, PA.
Q2'11 Complete validation of the Unifill prefilled syringe and its production process, as required by regulatory agencies.
Q2/Q3'11 Commence initial sales of validated Unifill syringes to sanofi-aventis and other pharmaceutical companies.
H2'11 Sign agreements for the Unifill syringe and other pipeline products with pharmaceutical and biotech companies.
2011 Secure regulatory approvals and expand sales of Unitract syringes via business development partners in India, Taiwan, Japan, and China.
2011 Enter into collaboration discussions with pharmaceutical, healthcare and medical device companies for pipeline products including the Unifill Select and Unitract Clinical Range syringes, thereby setting the stage for investments in their production lines.
This should put a few minds at ease!
Here's that better link again:
http://www.proactivenewsroom.com/Portals/52533/docs/unis31mar10.pdf
- Forums
- ASX - By Stock
- UNS
- new griffin report
new griffin report, page-3
-
- There are more pages in this discussion • 69 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)